BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24615866)

  • 1. Effects of protein engineering and rational mutagenesis on crystal lattice of single chain antibody fragments.
    Kalyoncu S; Hyun J; Pai JC; Johnson JL; Entzminger K; Jain A; Heaner DP; Morales IA; Truskett TM; Maynard JA; Lieberman RL
    Proteins; 2014 Sep; 82(9):1884-95. PubMed ID: 24615866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of scFv peptide-binding specificity for crystal chaperone development.
    Pai JC; Culver JA; Drury JE; Motani RS; Lieberman RL; Maynard JA
    Protein Eng Des Sel; 2011 May; 24(5):419-28. PubMed ID: 21217145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and biophysical characterization of an epitope-specific engineered Fab fragment and complexation with membrane proteins: implications for co-crystallization.
    Johnson JL; Entzminger KC; Hyun J; Kalyoncu S; Heaner DP; Morales IA; Sheppard A; Gumbart JC; Maynard JA; Lieberman RL
    Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):896-906. PubMed ID: 25849400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level secretion of recombinant monomeric murine and human single-chain Fv antibodies from Drosophila S2 cells.
    Gilmartin AA; Lamp B; Rümenapf T; Persson MA; Rey FA; Krey T
    Protein Eng Des Sel; 2012 Feb; 25(2):59-66. PubMed ID: 22160929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Crystal lattice engineering,' an approach to engineer protein crystal contacts by creating intermolecular symmetry: crystallization and structure determination of a mutant human RNase 1 with a hydrophobic interface of leucines.
    Yamada H; Tamada T; Kosaka M; Miyata K; Fujiki S; Tano M; Moriya M; Yamanishi M; Honjo E; Tada H; Ino T; Yamaguchi H; Futami J; Seno M; Nomoto T; Hirata T; Yoshimura M; Kuroki R
    Protein Sci; 2007 Jul; 16(7):1389-97. PubMed ID: 17586772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for the selection of monovalent antibodies that span protein dimer interfaces.
    Spangler JB; Moraga I; Jude KM; Savvides CS; Garcia KC
    J Biol Chem; 2019 Sep; 294(38):13876-13886. PubMed ID: 31387945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.
    Burmester J; Spinelli S; Pugliese L; Krebber A; Honegger A; Jung S; Schimmele B; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):671-85. PubMed ID: 11397088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv).
    Tu C; Terraube V; Tam AS; Stochaj W; Fennell BJ; Lin L; Stahl M; LaVallie ER; Somers W; Finlay WJ; Mosyak L; Bard J; Cunningham O
    J Biol Chem; 2016 Jan; 291(3):1267-76. PubMed ID: 26515064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal contacts engineering of aspartyl-tRNA synthetase from Thermus thermophilus: effects on crystallizability.
    Charron C; Kern D; Giegé R
    Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 1):1729-33. PubMed ID: 12351895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.
    Choi BD; Gedeon PC; Kuan CT; Sanchez-Perez L; Archer GE; Bigner DD; Sampson JH
    J Immunol Methods; 2013 Sep; 395(1-2):14-20. PubMed ID: 23806556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering an Anti-Transferrin Receptor ScFv for pH-Sensitive Binding Leads to Increased Intracellular Accumulation.
    Tillotson BJ; Goulatis LI; Parenti I; Duxbury E; Shusta EV
    PLoS One; 2015; 10(12):e0145820. PubMed ID: 26713870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
    Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
    MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
    Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
    J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-binding fragments with improved crystal lattice packing and enhanced conformational flexibility at the elbow region as crystallization chaperones.
    Bruce HA; Singer AU; Blazer LL; Luu K; Ploder L; Pavlenco A; Kurinov I; Adams JJ; Sidhu SS
    Protein Sci; 2024 Jul; 33(7):e5081. PubMed ID: 38924648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Neutralization of Centruroides noxius Venom Is Understood through a Structural Complex between Two Antibody Fragments and the Cn2 Toxin.
    Riaño-Umbarila L; Ledezma-Candanoza LM; Serrano-Posada H; Fernández-Taboada G; Olamendi-Portugal T; Rojas-Trejo S; Gómez-Ramírez IV; Rudiño-Piñera E; Possani LD; Becerril B
    J Biol Chem; 2016 Jan; 291(4):1619-1630. PubMed ID: 26589800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of conformations at crystal contacts in BPTI represent true low-energy structures: correspondence among lattice packing and molecular dynamics structures.
    Kossiakoff AA; Randal M; Guenot J; Eigenbrot C
    Proteins; 1992 Sep; 14(1):65-74. PubMed ID: 1384033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery.
    Fennell BJ; McDonnell B; Tam AS; Chang L; Steven J; Broadbent ID; Gao H; Kieras E; Alley J; Luxenberg D; Edmonds J; Fitz LJ; Miao W; Whitters MJ; Medley QG; Guo YJ; Darmanin-Sheehan A; Autin B; Shúilleabháin DN; Cummins E; King A; Krebs MR; Grace C; Hickling TP; Boisvert A; Zhong X; McKenna M; Francis C; Olland S; Bloom L; Paulsen J; Somers W; Jensen A; Lin L; Finlay WJ; Cunningham O
    MAbs; 2013; 5(6):882-95. PubMed ID: 23995618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering tandem single-chain Fv as cell surface reporters with enhanced properties of fluorescence detection.
    Gallo E; Snyder AC; Jarvik JW
    Protein Eng Des Sel; 2015 Oct; 28(10):327-37. PubMed ID: 25843939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization of small proteins assisted by green fluorescent protein.
    Suzuki N; Hiraki M; Yamada Y; Matsugaki N; Igarashi N; Kato R; Dikic I; Drew D; Iwata S; Wakatsuki S; Kawasaki M
    Acta Crystallogr D Biol Crystallogr; 2010 Oct; 66(Pt 10):1059-66. PubMed ID: 20944239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.